Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - CORNERSTONE THERAPEUTICS INC | b82915e10vq.htm |
| EX-10.1 - EX-10.1 - CORNERSTONE THERAPEUTICS INC | b82915exv10w1.htm |
| EX-31.2 - EX-31.2 - CORNERSTONE THERAPEUTICS INC | b82915exv31w2.htm |
| EX-32.2 - EX-32.2 - CORNERSTONE THERAPEUTICS INC | b82915exv32w2.htm |
| EX-31.1 - EX-31.1 - CORNERSTONE THERAPEUTICS INC | b82915exv31w1.htm |
| EX-10.3 - EX-10.3 - CORNERSTONE THERAPEUTICS INC | b82915exv10w3.htm |
| EX-10.2 - EX-10.2 - CORNERSTONE THERAPEUTICS INC | b82915exv10w2.htm |
Exhibit 32.1
CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO RULE 13a-14(b)
OF THE SECURITIES EXCHANGE ACT OF 1934 AND 18 U.S.C. SECTION 1350
PURSUANT TO RULE 13a-14(b)
OF THE SECURITIES EXCHANGE ACT OF 1934 AND 18 U.S.C. SECTION 1350
In connection with the Quarterly Report on Form 10-Q of Cornerstone Therapeutics Inc. (the
“Company”) for the period ended September 30, 2010 as filed with the Securities and Exchange
Commission on the date hereof (the “Report”), the undersigned, Craig A. Collard, President, Chief
Executive Officer and Interim Chief Financial Officer of the Company, hereby certifies, to the
knowledge of the undersigned, pursuant to 18 U.S.C. Section 1350, that:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: November 4, 2010
| /s/ Craig A. Collard | ||||
| Craig A. Collard | ||||
| President, Chief Executive Officer and Interim Chief Financial Officer (Principal Executive Officer) |
||||
This Certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. § 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed
“filed” by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended, and shall not be incorporated by reference into any filing of the Company under the
Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether
made before or after the date of this Report, irrespective of any general incorporation language
contained in such filing.
A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of
2002 has been provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.